Tamiflu correspondence with Roche

Correspondence between Fiona Godlee and Roche

29 October 2012

In October 2012 BMJ editor in chief Fiona Godlee reminded Roche, in a letter to board member John Bell, that the company had not made the full clinical study reports available. She emailed him again on 6 December to remind him he had yet to respond.

Click on individual jpegs to see them in more detail. Personal contact details have been redacted.

Competing interests: None declared

F Godlee, Editor in chief

BMJ, BMA House, Tavistock Square, London WC1H 9JR

Click to like: